New Delhi: The phase three human clinical trial of Covaxin, a candidate for the indigenously developed coronavirus vaccine, began at AIIMS here Thursday with Dr. MV Padma Srivastava, head of the main institute’s Neuroscience Center, and three others. volunteers who received the first dose. ‘Covaxin’ is being developed by Bharat …
Read More »Bharat Biotech’s Covaxin Phase 3 Trial Begins at AIIMS Delhi
